Mar 12, 2018 20:30 pm UTC| Business
TORONTO, March 12, 2018 -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announces that, further to its press release on March 9, 2018 whereby the Company...
Arch Therapeutics Provides Update on 510(k)
Mar 12, 2018 20:30 pm UTC| Business
FRAMINGHAM, Mass., March 12, 2018 -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of liquid, gel and solid hemostatic and wound care devices, today announced that it has utilized the Food...
Epizyme Appoints Oncology Industry Leader Michael Giordano, M.D., to its Board of Directors
Mar 12, 2018 20:30 pm UTC| Business
CAMBRIDGE, Mass., March 12, 2018 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced the appointment of Michael Giordano, M.D., to the...
Precision Therapeutics Appoints Kevin Hungerford as Vice President of Sales and Marketing
Mar 12, 2018 20:30 pm UTC| Business
MINNEAPOLIS, March 12, 2018 -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that it has appointed Kevin Hungerford as Global Vice President of Sales...
Mar 12, 2018 20:30 pm UTC| Business
BEDMINSTER, N.J. and DUBLIN, Ireland, March 12, 2018 -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular (CV)...
Mar 12, 2018 20:30 pm UTC| Business
BEDMINSTER, N.J.andDUBLIN, Ireland, March 12, 2018 -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular (CV)...
United States Steel Corporation Provides Full-Year 2018 Guidance
Mar 12, 2018 20:20 pm UTC| Business
PITTSBURGH, March 12, 2018 -- Today, United States Steel Corporation (NYSE:X) provided full-year 2018 guidance. The guidance reads as follows. Given the market dynamics primarily related to President Trump’s recent...